16 May 2008 14:44
RNS Number : 6763U
ReGen Therapeutics PLC
16 May 2008
16 May 2008
REGEN THERAPEUTICS PLC
(“ReGen” or the “Company”; Ticker: (RGT))
TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii): ReGen Therapeutics Plc 2. Reason for the notification: An acquisition or disposal of voting rights 3. Full name of person(s) subject to the notification obligation (iii): Andrew Clement Wilson 4. Full name of shareholder(s) (if difference from 3): As above 5. Date of the transaction and date on which the threshold is crossed or reached (v): 14th May 2008 6. Date on which issued notified: 16th May 2008 7. Threshold(s) that is/are crossed or reached: 12% 8. Notified details A: Voting rights attached to shares Class/type of share if possible using the ISIN Code GB00B28XMY25 Situation Previous to the triggering transaction (vi) – Number of Shares 1,372,000 Number of Voting Rights (viii) 1,372,000 Resulting situation after the triggering transaction (viii) – Number of Shares 1,387,000 Number of Voting Rights – Direct (x) 1,387,000 Number of Voting Rights – Indirect (xi) N/A % of voting rights – Direct 12.08% % of voting rights – Indirect N/A B: Financial Instruments Resulting situation after the triggering transaction (xii) Type of financial instrument N/A Expiration date (xiii) N/A Exercise/Conversion Period/Date (xiv) N/A Number of voting rights that may be acquired if the instrument is exercised/converted N/A % of voting rights N/A Total (A+B) Number of voting rights 1,387,000 % of voting rights 12.08% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv): STOCK IS REGISTERED IN GILTSPUR NOMINEES LIMITED Proxy Voting: 10. Name of the proxy holder: Giltspur Nominees Limited 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: N/A 14. Contact name: Patrick Wilson 15. Contact telephone number: 028 90 446000
For further information:
Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920
Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel No 020 7628 3396
David Scott/Nick Bealer
Alexander David Securities Limited
Tel: 020 7448 9800
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLAFMJTMMJBBJP
Sign In
Follow the stocks
